Table 1 Demographic data
Demographic data | All patients (n = 68) | LVH patients (n = 46) | Non-LVH patients (n = 22) | P value |
|---|---|---|---|---|
Age (years) | 78.4 (73.3–83.4) | 78.7 (74.5–79.9) | 76.2 (71.6–80.6) | 0.018 |
Female | 38 (55.9%) | 19 (41.3%) | 19 (86.4%) | <0.001 |
BMI (kg/m2) | 25.3 (23–8–27.8) | 24.8 (22.9–27.7) | 26.0 (24.2–27.7) | 0.235 |
SBP (mmHg) | 120.0 (110.0–140.0) | 120.0 (110.0–132.0) | 121.0 (112.5–140.0) | 0.256 |
DBP (mmHg) | 71.5(60.0–80.0) | 70.0 (60.0–80.0) | 80.0 (71.5–80.0) | 0.033 |
Heart rate (bpm) | 67.0 (57.0–77.0) | 69.0 (55.5–77.8) | 65.0 (59.0–73.8) | 0.854 |
Hypertension | 50 (73.5%) | 33 (71.7%) | 17 (77.3%) | 0.772 |
Type 2 diabetes | 19 (27.9%) | 10 (21.7%) | 9 (40.9%) | 0.148 |
Dyslipidemia | 27 (39.7%) | 18 (39.1%) | 9 (40.9%) | 1.000 |
Paroxysmal atrial fibrillation | 11 (16.2%) | 9 (19.6%) | 2 (9.1%) | 0.482 |
Coronary artery disease | 32 (47.1%) | 19 (41.3%) | 13 (59.1%) | 0.201 |
Previous myocardial infarction | 17 (25.0%) | 11 (23.9%) | 6 (27.3%) | 0.772 |
Previous CABG | 14 (20.6%) | 7 (15.2%) | 7 (31.8%) | 0.198 |
Previous PCI | 18 (26.5%) | 12 (26.1%) | 6 (27.3%) | 1.000 |
Peripheral artery disease | 6 (8.8%) | 4 (8.7%) | 2 (9.1%) | 1.000 |
Chronic obstructive pulmonary disease | 8 (11.8%) | 6 (13.0%) | 2 (9.1%) | 1.000 |
Medication use | ||||
ACEi | 31 (45.6%) | 20 (43.5%) | 11 (50.0%) | 0.795 |
ARBs | 19 (27.9%) | 13 (28.3%) | 6 (27.3%) | 1.000 |
CCBs | 14 (20.6%) | 8 (17.4%) | 6 (27.3%) | 0.356 |
Beta blocker | 47 (69.1%) | 33 (71.7%) | 14 (63.76%) | 0.579 |
Hydralazine/Nitrate | 11 (16.2%) | 8 (17.4%) | 3 (13.6%) | 1.000 |
Diuretic | 44 (64.7%) | 28 (60.9%) | 16 (72.7%) | 0.421 |
Days between echocardiogram and ECG | 14 (1.0–43.3) | 13.5(1.0–42.8) | 14 (3.3–47.8) | 0.506 |